Viewing Study NCT03652233


Ignite Creation Date: 2025-12-25 @ 3:00 AM
Ignite Modification Date: 2026-03-06 @ 9:34 AM
Study NCT ID: NCT03652233
Status: WITHDRAWN
Last Update Posted: 2019-06-20
First Post: 2018-08-20
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Afatinib and Nivolumab as Treatment for Recurrent/Metastatic Squamous Cell Carcinoma of the Head and Neck
Sponsor: Vanderbilt-Ingram Cancer Center
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Recurrent Squamous Cell Carcinoma of the Head or Neck View
None Metastatic Squamous Cell Carcinoma of the Head or Neck View
None Squamous Cell Carcinoma View
Keywords: